Ariad Investors' Attys Seek 30% Of $3.5M Class Settlement
By Alison Noon ( April 6, 2018, 4:37 PM EDT) -- Attorneys who won the revival of a securities class action at the First Circuit in 2016 have requested exactly 30 percent of the $3.5 million settlement that their three law firms subsequently reached on behalf of investors with Takeda Pharmaceutical Co. unit Ariad Pharmaceuticals Inc....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.